- All sections
- C - Chemistrymetallurgy
- C07F - Acyclic, carbocyclic, or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium
- C07F 9/24 - Esteramides
Patent holdings for IPC class C07F 9/24
Total number of patents in this class: 380
10-year publication summary
|
29
|
33
|
33
|
26
|
17
|
23
|
34
|
24
|
16
|
13
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Gilead Sciences, Inc. | 2220 |
22 |
| Cancer Targeted Technology LLC | 28 |
14 |
| Sony Group Corporation | 15597 |
11 |
| Sony Corporation | 30208 |
7 |
| Central Glass Company, Limited | 1291 |
7 |
| F. Hoffmann-La Roche AG | 7836 |
6 |
| Medivir AB | 111 |
6 |
| Suzhou Abogen Biosciences Co., Ltd. | 78 |
6 |
| Zevra Therapeutics, Inc. | 99 |
6 |
| The Regents of the University of California | 20720 |
5 |
| The Johns Hopkins University | 5875 |
5 |
| UPL Limited | 629 |
5 |
| Washington State University | 498 |
5 |
| Ascentawits Pharmaceuticals, Ltd. | 78 |
5 |
| LG Chem, Ltd. | 17921 |
4 |
| Sony Corporation of America | 403 |
4 |
| Centre National de La Recherche Scientifique | 11016 |
4 |
| Universite de Bretagne Occidentale | 106 |
4 |
| University of Guelph | 368 |
4 |
| Arysta LifeScience Inc. | 67 |
4 |
| Other owners | 246 |